Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23197752 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)
Condition: Primary Insomnia
Interventions: Drug: Suvorexant;   Drug: Dose-matched Placebo to Suvorexant

Indicates status has not been verified in more than two years